JPH0810325A - Syringe and container - Google Patents
Syringe and containerInfo
- Publication number
- JPH0810325A JPH0810325A JP6149771A JP14977194A JPH0810325A JP H0810325 A JPH0810325 A JP H0810325A JP 6149771 A JP6149771 A JP 6149771A JP 14977194 A JP14977194 A JP 14977194A JP H0810325 A JPH0810325 A JP H0810325A
- Authority
- JP
- Japan
- Prior art keywords
- cylinder
- sealing plug
- syringe
- intermediate sealing
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3132—Syringe barrels having flow passages for injection agents at the distal end of the barrel to bypass a sealing stopper after its displacement to this end due to internal pressure increase
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
(57)【要約】
【目的】 複数の薬剤を分割した室内に収納保存でき
て、連続的に該薬剤を投与できる注射器兼容器を提供す
る。
【構成】 中間密封栓により内部を複数の室に分割され
た注射器兼容器であって、注射器筒にバイパスを溝状に
切り欠いて直線状又は注射針取付け用突出部基部まで延
長したL字状に形成し、該直線状バイパス溝と先端に突
起を有する中間密封栓により、又はL字状バイパス溝と
突起を有する又は突起のない中間密封栓とにより薬剤を
流出できる流路を形成して薬剤の連続投与を実現する。
注射器筒は1本の円筒状で簡略な構造により製造コス
ト、製造工程、製剤コスト、衛生性、投与作業の操作
性、患者への苦痛低減において有利である。
(57) [Summary] [Object] To provide a syringe / container capable of storing and storing a plurality of medicines in a divided room and continuously administering the medicines. [Composition] A syringe / container whose inside is divided into a plurality of chambers by an intermediate sealing plug, wherein a bypass is cut out in a groove shape in a syringe barrel to form a straight line or an L-shape extending to a base of a protruding portion for attaching an injection needle. And a linear bypass groove and an intermediate sealing plug having a projection at the tip, or an L-shaped bypass groove and an intermediate sealing plug having a projection or having no projection to form a flow path through which a drug can flow out. Realize continuous administration of.
The syringe barrel has a single cylindrical and simple structure, and is advantageous in manufacturing cost, manufacturing process, formulation cost, hygiene, operability of administration work, and reduction of pain to a patient.
Description
【0001】[0001]
【産業上の利用分野】本発明は注射器兼容器に関し、詳
しくは一回の投与針の刺入れにより2種類以上の薬剤を
投与できる2室以上の薬剤保存用室を有する注射器兼容
器の改良に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a syringe / container, and more particularly, to an improvement of a syringe / container having two or more drug storage chambers capable of administering two or more kinds of drugs by inserting a single administration needle. It is a thing.
【0002】[0002]
【従来の技術】二種類の薬液を保存できる注射器として
例えば実公昭46−30627号、実公昭49−306
27号各公報等に提案されている、予め混合すると効力
を失うようなA,B二種類の薬液を分離して保存してお
き、投与の際には一液ずつ順次投与して患部において両
液を混合し薬効を発揮させる注射器兼容器がある。ま
た、特開昭58−81047号、特開昭58−1040
65号各公報には、造影剤流体と洗浄用流体とを一つの
シリンダーに保存し、連続してこの2種の流体を注射す
る注射器が提案されている。さらにまた、実公平4−1
2990号公報には二又は三種以上の異なる注射液を注
射筒の前部に取り付ける注射針ホルダの基部のカラー部
分に設けた溝状バイパスを流路として逐次注射すること
ができる注射器が提案されている。2. Description of the Related Art As syringes which can store two kinds of liquid medicine, for example, JP-B-46-30627 and JP-B-49-306.
No. 27, etc., the two types of drug solutions A and B, which lose their potency when mixed in advance, are separated and stored, and each solution is sequentially administered at the time of administration, and both are treated at the affected site. There is a syringe / container that mixes liquids and exerts a medicinal effect. Further, JP-A-58-81047 and JP-A-58-1040
Japanese Patent No. 65 proposes a syringe in which a contrast medium fluid and a cleaning fluid are stored in one cylinder and the two fluids are continuously injected. Furthermore, actual fairness 4-1
No. 2990 proposes a syringe capable of sequentially injecting two or more different injection solutions by using a groove-shaped bypass provided in a collar portion of a base portion of an injection needle holder attached to a front portion of an injection cylinder as a flow path. There is.
【0003】[0003]
【発明が解決しようとする課題】上記したような従来の
2室型注射器は、いずれも注射器を構成している注射
筒、滑栓、ピストンの構造が非常に複雑であること、従
ってその成形が困難で不経済あるためにさらには製造工
程での洗浄、殺菌等にも困難があるために製造コスト上
好ましくないこと、また注射器内の薬剤の品質保存に関
しては特に充分な配慮がされていないこと、などの問題
点を有している。本発明はこのような従来品の欠点を解
消し、二種類以上の薬剤を正確、かつ衛生的に保存でき
るとともに連続的に投与できる注射器兼容器を提供しよ
うとするものである。In the conventional two-chamber type syringe as described above, the structure of the syringe barrel, the stopper and the piston constituting the syringe is very complicated, and therefore the molding is difficult. Difficult and uneconomical, and also difficult to wash and sterilize in the manufacturing process, which is not preferable in terms of manufacturing cost, and there is no particular consideration given to the quality preservation of the drug in the syringe. , And so on. The present invention aims to solve the above-mentioned drawbacks of conventional products and to provide a syringe / container capable of accurately and sanitarily storing two or more drugs and continuously administering them.
【0004】[0004]
【課題を解決するための手段】上記課題を解決する手段
として本発明は、先端部に注射針取り付け用の管状の突
出部を有し、1又は2以上の中間密封栓により内部を複
数の室に分割された1本の筒内に複数の薬剤を収納して
開口部側を封止密封栓で封止し、薬剤投与時には該封止
密封栓に押棒を取り付けて筒内に押し込むことにより該
突出部から薬剤を流出させる注射器兼容器において、
(1) 上記筒の先端部側内壁面に筒軸方向に先端部に至り
さらに該突出部の基部まで先端部内壁面に沿って延長さ
れたL字状の1本以上のバイパス溝が切り欠き溝形状
に、且つその筒軸方向部分の長さが上記1又は2以上の
中間密封栓の筒軸方向長さ合計より長く設けられ、(2)
第1の中間密封栓が上記バイパス溝より開口部よりに位
置して筒内に嵌着されて筒先端部との間に第1室を形成
し、(3) 該第1の中間密封栓と上記封止密封栓との間に
第2室を形成するか又は該第1中間密封栓と該封止密封
栓との間に1以上の中間密封栓を設けてさらに1以上の
室を形成し、(4) 薬剤投与時には該第1中間密封栓を該
バイパス溝側に落としこむことにより筒内壁と該第1中
間密封栓との間に流路を形成して第1室内の薬剤及び第
2室の薬剤を連続的に流出させる、(5) またはさらに次
の中間密封栓をバイパス溝内に落とし込むことにより第
3室以下の薬剤を同様に連続的に流出させることを特徴
とする注射器兼容器を提供する。上記本発明の注射器兼
容器における特に好ましい実施態様として、上記第1中
間密封栓は薬剤投与時に筒内の最前の位置に押し込まれ
たときに上記L字状のバイパス溝を閉塞せず且つバイパ
ス溝部分以外の上記筒先端部内壁面に密着して該L字状
のバイパス溝と突出部内に連続した流路を形成できるも
のであること、あるいは上記第1中間密封栓はその先端
面に複数の突起を有し、薬剤投与時に筒内の最前の位置
に押し込まれたときに、該L字状バイパス溝、筒先端部
内壁と該突起の間の空隙及び突出部内に連続した流路を
形成できるものであることが挙げられる。As a means for solving the above-mentioned problems, the present invention has a tubular projection for attaching an injection needle at the tip end thereof, and one or more intermediate sealing plugs are provided inside the plurality of chambers. By accommodating a plurality of medicines in one cylinder divided into, the opening side is sealed with a sealing and sealing plug, and at the time of drug administration, a push rod is attached to the sealing and sealing stopper and pushed into the cylinder. In the syringe and container that allows the drug to flow out from the protruding part,
(1) One or more L-shaped bypass grooves are cut out on the inner wall surface of the cylinder on the tip side to extend to the tip in the cylinder axis direction and further extend along the inner wall surface of the tip to the base of the protrusion. The shape is such that the length of the cylinder axial direction portion thereof is longer than the total length of the one or more intermediate sealing plugs in the cylinder axial direction, (2)
The first intermediate sealing plug is located closer to the opening than the bypass groove and is fitted into the cylinder to form a first chamber between the first intermediate sealing plug and the cylinder tip, and (3) the first intermediate sealing plug. A second chamber is formed between the sealed sealing plug and one or more intermediate sealing plugs are provided between the first intermediate sealing plug and the sealed sealing plug to form one or more chambers. (4) At the time of drug administration, the first intermediate sealing plug is dropped into the bypass groove side to form a flow path between the inner wall of the cylinder and the first intermediate sealing plug, so that Syringe / container, characterized in that the drug in the chamber is continuously discharged (5) or the drug in the third chamber or lower is likewise continuously discharged by dropping the next intermediate sealing plug into the bypass groove. I will provide a. In a particularly preferred embodiment of the syringe / container of the present invention, the first intermediate sealing stopper does not close the L-shaped bypass groove when pushed into the foremost position in the cylinder at the time of drug administration and does not bypass the bypass groove. A portion which is in close contact with the inner wall surface of the cylinder tip portion other than the above portion and can form a continuous flow path in the L-shaped bypass groove and the projection portion, or the first intermediate sealing plug has a plurality of protrusions on its tip surface. And having an L-shaped bypass groove, a gap between the inner wall of the cylinder tip and the protrusion, and a continuous flow path in the protrusion when pushed into the frontmost position in the cylinder during drug administration. That is.
【0005】また、本発明は先端部に注射針取り付け用
の管状の突出部を有し、1又は2以上の中間密封栓によ
り内部を複数の室に分割された1本の筒内に複数の薬剤
を収納して開口部側を封止密封栓で封止し、薬剤投与時
には該封止密封栓に押棒を取り付けて筒内に押し込むこ
とにより該突出部から薬剤を流出させる注射器兼容器に
おいて、(1) 上記筒の先端部側内壁面に筒軸方向に先端
部に至る直線状のバイパス溝が切り欠き溝形状に、且つ
その筒軸方向長さが上記1又は2以上の中間密封栓の筒
軸方向長さ合計より長く設けられ、(2) その先端面に複
数の突起を有する第1の中間密封栓が上記バイパス溝よ
り開口部よりに位置して筒内に嵌着されて筒先端部との
間に第1室を形成し、(3) 該第1の中間密封栓と上記封
止密封栓との間に第2室を形成するか又は該第1中間密
封栓と該封止密封栓との間に1以上の中間密封栓を設け
てさらに1以上の室を形成し、(4) 薬剤投与時には該第
1中間密封栓を該バイパス溝側に落としこむことにより
該バイパス溝、筒先端部内壁と該第 1中間密封栓の突起
との間の空隙及び突出部内に連続した流路を形成して第
1室内の薬剤及び第2室の薬剤を連続的に流出させる、
(5) またはさらに次の中間密封栓をバイパス溝内に落と
し込むことにより第3室以下の薬剤を同様に連続的に流
出させることを特徴とする注射器兼容器を提供する。Further, according to the present invention, a tubular protrusion for attaching an injection needle is provided at the tip end, and the inside is divided into a plurality of chambers by one or more intermediate sealing plugs. In a syringe / container in which a drug is housed and the opening side is sealed with a sealing / sealing stopper, and when a drug is administered, a push rod is attached to the sealing / sealing stopper and pushed into the cylinder to cause the drug to flow out from the protruding portion, (1) On the inner wall surface on the tip end side of the cylinder, a linear bypass groove reaching the tip end in the cylinder axis direction is formed into a notched groove shape, and the length of the intermediate sealing plug in the cylinder axis direction is 1 or 2 or more. (2) A first intermediate sealing plug having a plurality of protrusions on its tip surface is provided longer than the total length in the cylinder axis direction, and is fitted into the cylinder at a position closer to the opening than the bypass groove, and the cylinder tip is attached. And a second chamber between the first intermediate sealing plug and the sealing sealing plug. Or at least one intermediate sealing plug is provided between the first intermediate sealing plug and the sealing sealing plug to further form one or more chambers. (4) The first intermediate sealing when administering a drug By dropping the plug into the bypass groove side, a space between the bypass groove, the inner wall of the cylinder tip and the protrusion of the first intermediate sealing plug, and a continuous flow path are formed in the protrusion to form a drug in the first chamber. And the drug in the second chamber is continuously discharged,
(5) Or a syringe / container characterized in that the medicine in the third or lower chamber is similarly continuously discharged by dropping the next intermediate sealing plug into the bypass groove.
【0006】上記した1本の筒内に複数の室とL字状あ
るいは直線状のバイパス溝を有し、バイパス溝がL字状
の場合には先端部に突起のない又は突起のある第1中間
密封栓を組み合わせ、バイパス溝が直線状の場合には先
端部に突起のある第1中間密封栓を組み合わせてなる本
発明の注射器兼容器において、該筒は筒軸に直交する断
面の外周が円形であることが特に好ましい実施態様であ
る。このように外形が単純な円筒状であることは製造
上、工程上有利である。また、本発明の注射器兼容器は
上記注射針取り付け用の管状の突出部に注射針取り付け
器具により投与針を取り付けて注射器組立体とすること
が特に好ましい実施態様である。A first chamber having a plurality of chambers and an L-shaped or straight-lined bypass groove in the above-mentioned single cylinder. When the bypass groove is L-shaped, there is no protrusion or a protrusion at the tip. In the syringe-cum-container of the present invention, which is formed by combining an intermediate sealing plug and, when the bypass groove is linear, combining a first intermediate sealing plug having a protrusion at the tip, the cylinder has an outer periphery of a cross section orthogonal to the cylinder axis. A circular shape is a particularly preferred embodiment. Such a simple outer shape is advantageous in manufacturing and process. In the syringe / container of the present invention, it is a particularly preferred embodiment that a dosing needle is attached to the tubular projection for attaching the injection needle by an injection needle attaching device to form a syringe assembly.
【0007】[0007]
【作用及び実施例】本発明の注射器兼容器の構造、作用
機構及びその特徴を実施例を挙げて詳細に説明するが、
本発明は該実施例にのみ限定されるところはない。図1
は本発明の一実施例の概略断面図である。図1の(a)
において、注射器兼容器1の注射筒(以下「筒」と略称
する)2の筒内面壁4には、筒長さ方向において筒中央
より若干先端部3よりの位置から筒先端部にいたるバイ
パス溝5が1本以上設けられており、該バイパス溝5は
投与用の針を取り付ける先端部の内壁面にまで延長され
ている。以下、この延長された部分をバイパス溝6とい
う。筒2の略中央部分において筒内壁面4に密着して嵌
着され、筒先端部3との間に第1室10を形成する第1
中間密封栓7はその先端面に例えば2〜4ケといった複
数個の突起が設けられている。また、筒の他の端部の開
口部側には筒内壁面4に密着して封止密封栓11が嵌着
され、該第1中間密封栓7は封止密封栓11及び筒内壁
面と共に第2室12を構成する。ACTION AND WORKING EXAMPLES The structure, working mechanism and features of the syringe / container of the present invention will be described in detail with reference to working examples.
The present invention is not limited to the examples. FIG.
FIG. 1 is a schematic sectional view of an embodiment of the present invention. Figure 1 (a)
In the syringe inner wall 4 of the syringe barrel 2 of the syringe / container 1 (hereinafter abbreviated as "cylinder"), a bypass groove extending from a position slightly distal to the tip 3 from the center of the barrel to the tip of the barrel in the length direction of the barrel. One or more 5 are provided, and the bypass groove 5 extends to the inner wall surface of the distal end portion to which the needle for administration is attached. Hereinafter, this extended portion is referred to as the bypass groove 6. The first chamber 10 is fitted in close contact with the inner wall surface 4 of the cylinder 2 at a substantially central portion thereof, and forms the first chamber 10 between the front end 3 and the cylinder.
The intermediate sealing plug 7 is provided with a plurality of protrusions, for example, 2 to 4 on its tip surface. Further, a sealing and sealing plug 11 is fitted on the opening side of the other end of the cylinder in close contact with the cylindrical inner wall surface 4, and the first intermediate sealing plug 7 together with the sealing and sealing plug 11 and the cylindrical inner wall surface. The second chamber 12 is configured.
【0008】図1の(a)のA−A′断面図を同図の
(c)に示す。筒外周は断面真円形であるが、バイパス
溝5は図示のように筒内壁面を切り欠いた溝であって、
筒内壁に沿って図示の例では2本設けられている。本発
明においてバイパス溝5は1本以上任意の本数設けてよ
い。図1の例においては、該バイパス溝5は円筒状の筒
内壁面4及び先細形状で管状に突出した突出部を有する
筒先端部の内壁面4′に沿って先端突出部内管部の基部
近傍に達するL字形のバイパス溝であり、溝の断面積は
投与時に先端に取り付けられる投与針の内径より若干広
く設計されている。図1の(b)は封止密封栓11の後
部側窪に接続する押棒を示す。同図の(d)は筒2の先
端部3において管状の突出部に接続される投与針を示
す。筒2内に嵌着される第1中間密封栓、封止密封栓
は、薬剤と接触する面13、13′、13′′、1
3′′′を、いずれも薬剤を汚染しない例えばフッ素系
樹脂フィルム等の合成樹脂を積層されている。本例の第
1中間密封栓7はその先端面に複数の突起8を有してい
て、最前の位置に押し込まれたときに、バイパス溝5と
共に該突起8と先端部の内壁4′との間の空隙にも流路
を形成することができるので薬剤のスムーズな流出を実
現できる。また、筒2の先端3は管状の筒口が突出し、
該管の周りを囲んで突出したカラー、及びルアーテーパ
ーチップを有しており、また筒口の開口は合成樹脂積層
ゴム栓で密封されている。A sectional view taken along the line AA 'of FIG. 1 (a) is shown in FIG. 1 (c). Although the outer circumference of the cylinder has a perfect circular cross section, the bypass groove 5 is a groove formed by cutting out the inner wall surface of the cylinder as shown in the drawing.
In the illustrated example, two are provided along the inner wall of the cylinder. In the present invention, one or more bypass grooves 5 may be provided in any number. In the example of FIG. 1, the bypass groove 5 is formed in the vicinity of the base of the inner tube portion of the tip projection along the inner wall surface 4 of the cylinder tip and the inner wall surface 4 ′ of the cylinder tip portion having the protruding portion protruding in the shape of a taper. It is an L-shaped bypass groove reaching up to, and the cross-sectional area of the groove is designed to be slightly larger than the inner diameter of the administration needle attached to the tip during administration. FIG. 1B shows a push rod connected to the rear side recess of the sealing and sealing plug 11. (D) of the figure shows a dosing needle connected to a tubular protrusion at the tip 3 of the barrel 2. The first intermediate sealing plug and the sealing sealing plug, which are fitted in the cylinder 2, are the surfaces 13, 13 ', 13 "', 1 which come into contact with the medicine.
3 '''is laminated with a synthetic resin such as a fluorine resin film that does not contaminate the chemicals. The first intermediate sealing plug 7 of this example has a plurality of protrusions 8 on its tip surface, and when pushed into the foremost position, the protrusion 8 and the inner wall 4'of the tip portion together with the bypass groove 5 are formed. Since a flow path can be formed in the space between them, a smooth outflow of the drug can be realized. In addition, the tip 3 of the tube 2 has a tubular tube mouth protruding,
It has a protruding collar surrounding the tube and a luer taper tip, and the opening of the tube mouth is sealed with a synthetic resin laminated rubber stopper.
【0009】図2は本発明の他の実施例の概略断面図で
あって、注射器兼容器15の注射筒(以下「筒」と略称
する)16の筒内面壁18には、筒長さ方向において筒
中央より若干先端部17よりの位置から筒先端部17ま
でのバイパス溝19が設けられている。先端面に突起2
1を有する第1中間密封栓20を筒内に嵌着して第1室
23を構成し、また筒他端の開口部22において筒内に
嵌着した封止密封栓24により第2室25を構成してい
る点は図1の場合と同様であるが、バイパス溝19が先
端部内壁には沿っておらず直線状であり、第1中間密封
栓を最前の位置に押し込んだときに該直線状バイパス溝
と、第1中間密封栓の先端の突起と先端部内壁の間に形
成される空隙及び突出部内の中空部分との間に連続した
流路が形成して、薬剤を流出させる。また筒、密封栓、
先端筒口のゴム栓等の形状も図1のものと異なっている
例である。FIG. 2 is a schematic cross-sectional view of another embodiment of the present invention, in which a cylinder inner surface wall 18 of an injection cylinder (hereinafter abbreviated as "cylinder") 16 of a syringe / container 15 has a cylinder length direction. A bypass groove 19 is provided from a position slightly closer to the tip end portion 17 than the center of the cylinder to the tip end portion 17 of the cylinder. Protrusion 2 on the tip surface
The first intermediate sealing plug 20 having No. 1 is fitted into the cylinder to form the first chamber 23, and the second sealing chamber 24 is fitted into the cylinder at the opening 22 at the other end of the cylinder. 1 is the same as in the case of FIG. 1, but the bypass groove 19 is linear and does not extend along the inner wall of the tip portion, and when the first intermediate sealing plug is pushed to the foremost position, A continuous flow path is formed between the linear bypass groove, the gap formed between the protrusion at the tip of the first intermediate sealing plug and the inner wall of the tip, and the hollow portion in the protrusion to allow the drug to flow out. In addition, a cylinder, a sealing plug,
The shape of the rubber plug or the like at the tip end of the barrel is also an example different from that of FIG.
【0010】本発明の図1の注射筒2、図2の注射筒1
6においては、バイパス溝5又は19は上述のように筒
内壁面を切り欠いたL字状又は直線状の溝形であるの
で、筒外周にバイパスの存在による突起はなくてよいた
め、筒の外形は円筒形状、断面外周は円形の簡単な形状
にすることができる。しかも本発明ではバイパス溝は薬
剤を保持する筒そのものに形成されていて構造上非常に
簡単で、製造上の衛生性は向上し、かつ製造コストも複
雑な構造の従来品より大幅に低減できる。1 and 2 of the present invention.
6, the bypass groove 5 or 19 has an L-shape or a linear groove shape in which the inner wall surface of the cylinder is cut off as described above, and therefore a protrusion due to the presence of the bypass on the outer circumference of the cylinder is not necessary. The outer shape can be a simple shape with a cylindrical shape and the cross-section outer circumference with a circular shape. Moreover, in the present invention, the bypass groove is formed in the cylinder itself for holding the medicine, and is structurally very simple, and the hygiene in manufacturing is improved, and the manufacturing cost can be greatly reduced as compared with the conventional product having a complicated structure.
【0011】図3は本発明の図2の注射器兼容器による
薬液の投与の説明図である。図2の注射器の筒16の先
端17に投与針26を堅く取り付け、封止密封栓24の
後部には押棒27を付け、該押棒27により封止密封栓
24を筒16の中央に圧入することにより、第1中間密
封栓20は第1室23に押し込められ、第1室23内の
薬液は第1中間密封栓の圧入により筒先端の突出部(筒
口)側へ押し出され、最終的に第1中間密封栓が筒内先
端まで押し込められると薬液は筒内のバイパス溝5及び
第1中間密封栓20の3ケの突起21と先端部内壁面と
の空隙、突出部内に連続して形成される流路を通って流
出し、人体に投与される。その後続いて第2室25内の
薬液がバイパス溝5及び突起21の間を通って流出す
る。FIG. 3 is an explanatory view of the administration of the liquid medicine by the syringe / container of FIG. 2 of the present invention. A dosing needle 26 is firmly attached to the tip 17 of the cylinder 16 of the syringe of FIG. 2, a push rod 27 is attached to the rear part of the sealing and sealing plug 24, and the sealing and sealing plug 24 is pressed into the center of the barrel 16 by the pushing rod 27. As a result, the first intermediate sealing plug 20 is pushed into the first chamber 23, and the chemical liquid in the first chamber 23 is pushed out toward the protruding portion (cylindrical mouth) side of the cylinder tip by the press-fitting of the first intermediate sealing plug, and finally the first When the first intermediate sealing plug is pushed to the tip of the cylinder, the chemical is continuously formed in the bypass groove 5 in the cylinder and the gaps between the three projections 21 of the first intermediate sealing plug 20 and the inner wall surface of the tip part, and the projection part. It flows out through the flow path and is administered to the human body. After that, the chemical liquid in the second chamber 25 subsequently flows out through between the bypass groove 5 and the protrusion 21.
【0012】図4は本発明の更に別の実施例である3室
を有する注射器兼容器の概略断面図である。同図におい
て注射筒(以下「筒」と略称する)16内には第1中間
密封栓20、第2中間密封栓24及び封止密封栓28を
図示のように嵌着して、第1室23,第2室25及び第
3室29を構成し、各室内にはそれぞれ薬剤を保持す
る。図4の注射器兼容器による薬剤投与を図5の概略説
明図に示す。図3のバイパスと同様に押棒により封止密
封栓を圧入することにより順次薬剤を流出させるが、図
示の状態は第1中間密封栓20及び第1中間密封栓24
が完全にバイパス溝19部分に嵌入しても両者を合わせ
た筒軸方向長さよりバイパス溝19の長さの方が若干長
くなるように設計してあるので、第3室内の薬剤もバイ
パスを経由して流出できる。FIG. 4 is a schematic sectional view of a syringe / container having three chambers, which is another embodiment of the present invention. In the figure, a first intermediate sealing plug 20, a second intermediate sealing plug 24, and a sealing sealing plug 28 are fitted in an injection cylinder (hereinafter abbreviated as “cylinder”) 16 as shown in the drawing, and the first chamber 23, the second chamber 25, and the third chamber 29 are formed, and each chamber holds a drug. Drug administration by the syringe / container of FIG. 4 is shown in a schematic explanatory view of FIG. Similarly to the bypass of FIG. 3, the sealing and sealing plug is press-fitted with the push rod to sequentially flow out the drug, but the state shown is the first intermediate sealing plug 20 and the first intermediate sealing plug 24.
Since the bypass groove 19 is designed to be slightly longer than the total length of the bypass groove 19 even if it is completely inserted into the bypass groove 19, the drug in the third chamber also passes through the bypass. And can be leaked.
【0013】図6は本発明の更に別の実施例であって、
L字形のバイパス溝19と先端に突起がなく筒先端部内
部形状と相似形の先端面を有する第1中間密封栓を有す
る注射器兼容器の概略説明図である。第1中間密封栓を
最前の位置お押し込んだ場合にも該L字形のバイパス溝
19と突出部の内部との間に流路が形成されるようにな
っていて、この例では注射器兼容器内に残留する薬剤量
が非常に少量となる。なお、本例においては、注射器兼
容器先端のゴム栓で封止した筒口部分に接続器具30を
取り付けて、該接続器具31に両頭針31を付け、針先
端はキャップでカバーした注射器兼容器組立体を示して
ある。キャップは押棒を兼用するものであってもよい。FIG. 6 shows still another embodiment of the present invention,
It is a schematic explanatory view of a syringe-cum-container having an L-shaped bypass groove 19 and a first intermediate sealing stopper having a tip end surface that is similar in shape to the internal shape of the cylinder tip without a projection at the tip. A flow path is formed between the L-shaped bypass groove 19 and the inside of the protruding portion even when the first intermediate sealing plug is pushed into the foremost position. In this example, in the syringe / container The amount of drug remaining in is very small. In this example, the connecting device 30 is attached to the tube mouth portion sealed with a rubber stopper at the tip of the syringe / container, the double-ended needle 31 is attached to the connecting device 31, and the needle tip is covered with a cap. A solid is shown. The cap may also serve as the push rod.
【0014】図7の(a)に本発明の第1中間密封栓の
他の具体例の部分断面図を、同図の(b)に先端面の概
略説明図を示す。8−1,8−2及び8−3の3ケの突
起を有し、薬剤と接触する面を合成樹脂フィルム13′
で積層されたものである。FIG. 7A is a partial cross-sectional view of another specific example of the first intermediate sealing plug of the present invention, and FIG. 7B is a schematic explanatory view of the tip end surface. 8-1, 8-2, and 8-3 have three protrusions, and the surface contacting with the drug is a synthetic resin film 13 '.
It is laminated in.
【0015】本発明の注射器兼容器を構成する材質とし
ては、この種の技術分野で公知の材質を用いることがで
きる。例えば、筒、押棒、接続器具等の材質としては合
成樹脂、例えば環状オレフィン系化合物又は架橋多環式
炭化水素系化合物を重合体成分とする樹脂、ポリオレフ
ィン系樹脂、ポリカーボネート樹脂、ポリメチルペンテ
ン樹脂から選ばれる樹脂及び樹脂組成物、該樹脂及び/
又は樹脂組成物とエチレン−酢酸ビニル共重合体もしく
はそのケン化物との混合物、アモルファスナイロン及び
ナイロンからなる群から選ばれる1以上が挙げられ、あ
るいはさらに表面に酸化ケイ素又はアルミニウム蒸着樹
脂フィルムを1種以上積層してバリヤー性を向上した樹
脂等が挙げられる。本発明の密封栓、密封用ゴム栓の材
質としてはこの種の注射器兼容器に一般的に使用される
ゴム類が使用でき、例えばポリブタジエン(BR)、ポ
リイソプレン(IR)、イソブチレン−イソプレン共重
合体(IIR)、IIRの塩素化ゴム(CIIR)又は
IIRの臭素化ゴム、エチレン−プロピレン−非共役重
合体ゴム(EPDM)などが挙げられる。また、ゴム成
形栓の表面の少なくとも薬剤に接触する面には該薬剤を
汚染しない合成樹脂、例えばフッ素系樹脂等を積層する
ことも好ましい実施の態様である。本発明の注射器兼容
器は、射出成形、金型を使用した成形等その材質、形態
に応じて公知の成形技術を適用して成形することができ
る。As a material forming the syringe / container of the present invention, a material known in this kind of technical field can be used. For example, as a material for a cylinder, a push rod, a connecting device or the like, a synthetic resin, for example, a resin containing a cyclic olefin compound or a crosslinked polycyclic hydrocarbon compound as a polymer component, a polyolefin resin, a polycarbonate resin, a polymethylpentene resin is used. Selected resin and resin composition, the resin and / or
Or a mixture of a resin composition and an ethylene-vinyl acetate copolymer or a saponified product thereof, one or more selected from the group consisting of amorphous nylon and nylon, or one kind of silicon oxide or aluminum vapor-deposited resin film on the surface. Examples thereof include resins that are laminated and have improved barrier properties. As the material of the sealing stopper and the sealing rubber stopper of the present invention, rubbers generally used in this kind of syringe and container can be used. For example, polybutadiene (BR), polyisoprene (IR), isobutylene-isoprene copolymer Examples thereof include compound (IIR), IIR chlorinated rubber (CIIR) or IIR brominated rubber, and ethylene-propylene-non-conjugated polymer rubber (EPDM). It is also a preferred embodiment that a synthetic resin that does not contaminate the drug, such as a fluorine-based resin, is laminated on at least the surface of the rubber molding stopper that contacts the drug. The syringe / container of the present invention can be molded by applying a known molding technique, such as injection molding, molding using a mold, or the like, depending on its material and form.
【0016】本発明の2室以上の複数の室を有し、各室
内に保持する薬剤を順次連続的に流出して人体等に投与
する注射器兼容器が非常に有利に適用される薬剤の具体
例を以下に説明する。第1室には例えばプロカイン、テ
トラカイン、アミノ安息香酸エチル、オキシプロカイン
エステル系化合物、リドカイン、メピバカイン、ジブカ
イン、オキセサゼイン(酸アミド系化合物)を0.1〜
0.5重量%注射用蒸留水又はアルコールに溶解して製
剤としたものなどの局所麻酔剤、ヨード造影剤等。第2
室には例えばテトラサイクリン系、キノリン系、アミノ
配糖体、マクロライド系などの抗生物質、例えばステロ
イドホルモン、甲状腺ホルモン、脳下垂体ホルモンなど
のホルモン、インターフェロン、ヒアルロン酸、ピリン
系薬剤等の本剤。ホルモン剤、インターフェロン、抗生
物質等は注射時の刺激が強いため局所麻酔剤との混合投
与が考えられるが、局所麻酔剤との製剤あるいは混合し
ての投与では、薬の効果(力価)の低下,変質、薬害発
生等の問題が生じてしまう。上記のように本発明の注射
器兼容器を適用して第1室、第2室に分離して薬剤を保
持しておき、先ず第1室内の局所麻酔剤を投与して局所
麻酔した後、続いて第2室の薬剤が投与されるので上記
の問題は解消し、薬の効果の向上、製剤の簡素化、容易
化、及び薬の適用範囲の拡大を実現できる。さらに本発
明の3室に分離した注射器兼容器によれば、例えば第1
室から局所麻酔剤、第2室から本剤、第3室から生理食
塩水のように連続して投与することができる。A syringe / container which has two or more chambers according to the present invention and in which the drug held in each chamber is continuously and sequentially discharged and administered to a human body, etc. is very advantageously applied. An example will be described below. In the first chamber, for example, procaine, tetracaine, ethyl aminobenzoate, oxyprocaine ester-based compound, lidocaine, mepivacaine, dibucaine, oxesazein (acid amide-based compound) are added in an amount of 0.1 to 0.1.
Local anesthetics such as those prepared by dissolving in 0.5% by weight of distilled water for injection or alcohol, and iodine contrast agents. Second
For example, tetracycline-type, quinoline-type, aminoglycoside-, macrolide-type, and other antibiotics such as steroid hormones, thyroid hormones, pituitary hormones, and other hormones, interferon, hyaluronic acid, and pyrin-type drugs are used in the chamber. Hormonal agents, interferons, antibiotics, etc., may be mixed with local anesthetics because of strong irritation at the time of injection. Problems such as deterioration, deterioration, and chemical damage will occur. As described above, the syringe / container of the present invention is applied to separate the first chamber and the second chamber to retain the drug, and first, the local anesthetic in the first chamber is administered to perform local anesthesia, and then, Since the drug in the second chamber is administered, the above problems can be solved, and the effect of the drug can be improved, the formulation can be simplified and facilitated, and the range of application of the drug can be expanded. Furthermore, according to the syringe / container separated into three chambers of the present invention, for example, the first
The local anesthetic can be administered from the chamber, the agent can be administered from the second chamber, and the saline can be administered from the third chamber.
【0017】[0017]
【発明の効果】本発明の注射器兼容器の効果は以下の通
りである。 1)構造が比較的に簡単であり、外形状も筒部分は単純
な円筒形であるため、製造コスト、殺菌作業、保存等に
も簡便であり、経済的である。 2)筒内の薬剤は単品で投与できるので、抗生物質等の
不安定な薬でも製剤を簡素化できる。 3)1本の注射筒から2種類又は3種類の薬剤を連続し
て衛生的に投与できるので、投与作業も簡素化できる。 4)連続的投与により薬効の低下をなくし、さらには併
用効果も期待できる。 5)混合投与でなく、時間差投与できるので、例えば局
所麻酔後に連続して抗生物質等を投与できるので患者の
苦痛が低減される。The effects of the syringe / container of the present invention are as follows. 1) Since the structure is relatively simple and the outer shape is a simple cylindrical portion, the manufacturing cost, sterilization work, storage, etc. are simple and economical. 2) Since the drug in the cylinder can be administered as a single item, the formulation of the unstable drug such as an antibiotic can be simplified. 3) Since two or three types of drugs can be continuously and hygienically administered from one syringe, the administration work can be simplified. 4) The continuous administration eliminates the decrease in drug efficacy and can be expected to have a combined effect. 5) Since the administration can be performed at a time difference instead of mixed administration, for example, antibiotics and the like can be continuously administered after local anesthesia, so that the patient's pain is reduced.
【図1】は本発明の注射器兼容器の一実施例を説明する
概略断面図である。FIG. 1 is a schematic cross-sectional view illustrating an embodiment of the syringe / container of the present invention.
【図2】は本発明の注射器兼容器の他の実施例を説明す
る概略断面図である。FIG. 2 is a schematic sectional view for explaining another embodiment of the syringe / container of the present invention.
【図3】は図2の本発明注射器兼容器で第2室の薬液を
投与している状態を説明する概略断面図である。FIG. 3 is a schematic cross-sectional view illustrating a state in which the liquid medicine of the second chamber is being administered by the syringe / container of the present invention in FIG.
【図4】は本発明のさらに他の実施例である3室を有す
る注射器兼容器を説明する概略断面図である。FIG. 4 is a schematic cross-sectional view illustrating a syringe / container having three chambers according to still another embodiment of the present invention.
【図5】は図4の本発明注射器兼容器において第3室の
薬液を投与している状態を説明する概略断面図である。FIG. 5 is a schematic cross-sectional view illustrating a state in which the liquid medicine of the third chamber is being administered in the syringe / container of the present invention in FIG.
【図6】は本発明のさらに他の実施例であって両頭の投
与針付き注射器兼容器を説明する概略断面図である。FIG. 6 is a schematic cross-sectional view for explaining a double-headed syringe / container with a dosing needle according to still another embodiment of the present invention.
【図7】は本発明の第1中間密封栓の一具体例の概略説
明図で部分断面及び正面図を示す。FIG. 7 is a schematic explanatory view of a specific example of a first intermediate sealing plug of the present invention, showing a partial cross section and a front view.
1 注射器兼容器、 2 筒(注射筒)、 3
先端部、4 筒内面、 5,5′ バイパ
ス溝、 6 バイパス溝、7 第1中間密封栓、 8
突起、 9 開口部、10 第1室、
11 封止密封栓、 12 第2室、1
3′,13′′,13′′′ 合成樹脂フィルム、14
カラー,ルアーチップ先端、 15
注射器兼容器、16 筒(注射筒)、 17 先端
部、18 筒内面、 19 バイパス溝、
20 第1中間密封栓、21 突起、 2
2 開口部、 23 第1室、24 封止密封
栓、 25 第2室、 26 投与部、2
7 押棒、 28 第2中間密封栓、 29
第3室、30 接続器具、 31 両頭針。1 syringe and container, 2 cylinders (syringe), 3
Tip part, 4 Inner surface of cylinder, 5, 5'Bypass groove, 6 Bypass groove, 7 First intermediate sealing plug, 8
Protrusion, 9 opening, 10 first chamber,
11 sealing and sealing plug, 12 second chamber, 1
3 ′, 13 ″, 13 ″ ″ synthetic resin film, 14
Color, tip of lure tip, 15
Syringe / container, 16 cylinders (injection cylinder), 17 tip part, 18 cylinder inner surface, 19 bypass groove,
20 first intermediate sealing plug, 21 protrusion, 2
2 Opening part, 23 1st chamber, 24 Sealing sealing stopper, 25 2nd chamber, 26 Dosing part, 2
7 Push rod, 28 2nd intermediate sealing plug, 29
3rd chamber, 30 connecting device, 31 double-ended needle.
Claims (8)
部を有し、1又は2以上の中間密封栓により内部を複数
の室に分割された1本の筒内に複数の薬剤を収納して開
口部側を封止密封栓で封止し、薬剤投与時には該封止密
封栓に押棒を取り付けて筒内に押し込むことにより該突
出部から薬剤を流出させる注射器兼容器において、(1)
上記筒の先端部側内壁面に筒軸方向に先端部に至りさら
に該突出部の基部まで先端部内壁面に沿って延長された
L字状の1本以上のバイパス溝が切り欠き溝形状に、且
つその筒軸方向部分の長さが上記1又は2以上の中間密
封栓の筒軸方向長さ合計より長く設けられ、(2) 第1の
中間密封栓が上記バイパス溝より開口部よりに位置して
筒内に嵌着されて筒先端部との間に第1室を形成し、
(3) 該第1の中間密封栓と上記封止密封栓との間に第2
室を形成するか又は該第1中間密封栓と該封止密封栓と
の間に1以上の中間密封栓を設けてさらに1以上の室を
形成し、(4) 薬剤投与時には該第1中間密封栓を該バイ
パス溝側に落としこむことにより筒内壁と該第1中間密
封栓との間に流路を形成して第1室内の薬剤及び第2室
の薬剤を連続的に流出させる、(5) またはさらに次の中
間密封栓をバイパス溝内に落とし込むことにより第3室
以下の薬剤を同様に連続的に流出させることを特徴とす
る注射器兼容器。1. A plurality of medicines are contained in a single cylinder having a tubular projection portion for attaching an injection needle at a tip portion and having an interior divided into a plurality of chambers by one or more intermediate sealing stoppers. In the syringe / container in which the opening side is sealed with a sealing / sealing stopper, and when the drug is administered, a push rod is attached to the sealing / sealing stopper and pushed into the cylinder to allow the medicine to flow out from the protruding portion.
One or more L-shaped bypass grooves extending along the inner wall surface of the distal end portion of the cylinder extending in the axial direction of the cylinder to the base portion of the protruding portion and extending along the inner wall surface of the distal end portion in a notched groove shape, The length of the cylinder axial direction portion is provided longer than the total length of the one or more intermediate sealing plugs in the cylindrical axial direction, and (2) the first intermediate sealing plug is located closer to the opening than the bypass groove. And is fitted into the cylinder to form a first chamber between the cylinder and the tip,
(3) A second gap is provided between the first intermediate sealing plug and the sealing sealing plug.
Forming a chamber or providing one or more intermediate sealing plugs between the first intermediate sealing plug and the sealing sealing plug to further form one or more chambers; By dropping the sealing plug into the bypass groove side, a flow path is formed between the inner wall of the cylinder and the first intermediate sealing plug to continuously flow out the drug in the first chamber and the drug in the second chamber. 5) Alternatively, by dropping the next intermediate sealing plug into the bypass groove, the drug in the third chamber and thereafter can be continuously continuously discharged in the same manner.
の最前の位置に押し込まれたときに上記L字状のバイパ
ス溝を閉塞せず且つバイパス溝部分以外の上記筒先端部
内壁面に密着して該L字状のバイパス溝と突出部内に連
続した流路を形成できるものであることを特徴とする請
求項1記載の注射器兼容器。2. The first intermediate sealing plug does not close the L-shaped bypass groove when pushed into the foremost position in the cylinder at the time of drug administration, and does not cover the inner wall surface of the cylinder tip portion other than the bypass groove portion. 2. The syringe / container according to claim 1, wherein a continuous flow path can be formed in close contact with the L-shaped bypass groove and in the protruding portion.
の突起を有し、薬剤投与時に筒内の最前の位置に押し込
まれたときに、該L字状バイパス溝、筒先端部内壁と該
突起の間の空隙及び突出部内に連続した流路を形成でき
るものであることを特徴とする請求項1記載の注射器兼
容器。3. The first intermediate sealing plug has a plurality of protrusions on its tip surface, and when the first intermediate sealing plug is pushed into the foremost position in the cylinder during drug administration, the L-shaped bypass groove and the inner wall of the cylinder tip part. The syringe / container according to claim 1, wherein a continuous flow path can be formed in the space between the protrusion and the protrusion and in the protrusion.
部を有し、1又は2以上の中間密封栓により内部を複数
の室に分割された1本の筒内に複数の薬剤を収納して開
口部側を封止密封栓で封止し、薬剤投与時には該封止密
封栓に押棒を取り付けて筒内に押し込むことにより該突
出部から薬剤を流出させる注射器兼容器において、(1)
上記筒の先端部側内壁面に筒軸方向に先端部に至る直線
状のバイパス溝が切り欠き溝形状に、且つその筒軸方向
長さが上記1又は2以上の中間密封栓の筒軸方向長さ合
計より長く設けられ、(2) その先端面に複数の突起を有
する第1の中間密封栓が上記バイパス溝より開口部より
に位置して筒内に嵌着されて筒先端部との間に第1室を
形成し、(3) 該第1の中間密封栓と上記封止密封栓との
間に第2室を形成するか又は該第1中間密封栓と該封止
密封栓との間に1以上の中間密封栓を設けてさらに1以
上の室を形成し、(4) 薬剤投与時には該第1中間密封栓
を該バイパス溝側に落としこむことにより該バイパス
溝、筒先端部内壁と該第 1中間密封栓の突起との間の空
隙及び突出部内に連続した流路を形成して第1室内の薬
剤及び第2室の薬剤を連続的に流出させる、(5) または
さらに次の中間密封栓をバイパス溝内に落とし込むこと
により第3室以下の薬剤を同様に連続的に流出させるこ
とを特徴とする注射器兼容器。4. A plurality of medicines are contained in a single cylinder, which has a tubular protrusion for attaching an injection needle at its tip and whose inside is divided into a plurality of chambers by one or more intermediate sealing stoppers. In the syringe / container in which the opening side is sealed with a sealing / sealing stopper, and when the drug is administered, a push rod is attached to the sealing / sealing stopper and pushed into the cylinder to allow the medicine to flow out from the protruding portion.
A linear bypass groove extending to the tip end in the cylinder axis direction is formed in a notched groove shape on the inner wall surface on the tip end side of the cylinder, and the length of the intermediate sealing plug in the cylinder axis direction is 1 or 2 or more in the cylinder axis direction. (2) A first intermediate sealing plug having a plurality of protrusions on its tip end surface is provided at a position closer to the opening than the bypass groove, and fitted into the cylinder to form a cylinder end. Forming a first chamber therebetween, and (3) forming a second chamber between the first intermediate sealing plug and the sealing sealing plug, or the first intermediate sealing plug and the sealing sealing plug. One or more intermediate sealing plugs are provided between the two to form one or more chambers. (4) When administering a drug, the first intermediate sealing plug is dropped into the bypass groove side so that the bypass groove and the tip end portion of the cylinder. A continuous flow path is formed in the space between the inner wall and the protrusion of the first intermediate sealing plug and the protrusion to connect the drug in the first chamber and the drug in the second chamber. Manner to flow out, (5) or a syringe-cum-container further characterized by the following intermediate sealing plug thereby flow out the third chamber following drug by dropping it into the bypass groove likewise continuously.
形であることを特徴とする請求項1ないし請求項4のい
ずれかに記載の注射器兼容器。5. The syringe / container according to any one of claims 1 to 4, wherein the cross-section of the cylinder orthogonal to the cylinder axis has a circular outer periphery.
注射針取り付け器具により投与針を取り付けて注射器組
立体としてなる請求項1ないし請求項5のいずれかに記
載の注射器兼容器。6. The syringe / container according to any one of claims 1 to 5, wherein an injection needle is attached to the tubular projection for attaching the injection needle by an injection needle attaching device to form a syringe assembly.
分が、環状オレフィン系化合物又は架橋多環式炭化水素
系化合物を重合体成分とする樹脂、ポリオレフィン系樹
脂、ポリカーボネート樹脂、ポリメチルペンテン樹脂か
ら選ばれる樹脂及び樹脂組成物、該樹脂及び/又は樹脂
組成物とエチレン−酢酸ビニル共重合体もしくはそのケ
ン化物との混合物、アモルファスナイロン及びナイロン
からなる群から選ばれる1以上からなる、あるいはさら
に表面に酸化ケイ素又はアルミニウム蒸着樹脂フィルム
を1種以上積層してなるものであることを特徴とする請
求項1ないし請求項6のいずれかに記載の注射器兼容
器。7. A resin containing a cyclic olefin compound or a cross-linked polycyclic hydrocarbon compound as a polymer component, a polyolefin resin, a polycarbonate resin, and polymethylpentene, except for the sealing and intermediate sealing plugs. A resin and a resin composition selected from resins, a mixture of the resin and / or the resin composition and an ethylene-vinyl acetate copolymer or a saponified product thereof, and one or more selected from the group consisting of amorphous nylon and nylon, or The syringe / container according to any one of claims 1 to 6, further comprising one or more kinds of silicon oxide or aluminum vapor-deposited resin film laminated on the surface.
形栓であって少なくとも薬剤と接触する面に該薬剤を汚
染しない合成樹脂フィルムを積層されてなるものである
ことを特徴とする請求項1ないし請求項6のいずれかに
記載の注射器兼容器。8. The sealing cap and the intermediate sealing plug are rubber molding plugs, and are formed by laminating a synthetic resin film which does not contaminate the drug on at least the surface in contact with the drug. The syringe and container according to any one of claims 1 to 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6149771A JPH0810325A (en) | 1994-06-30 | 1994-06-30 | Syringe and container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6149771A JPH0810325A (en) | 1994-06-30 | 1994-06-30 | Syringe and container |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0810325A true JPH0810325A (en) | 1996-01-16 |
Family
ID=15482379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6149771A Pending JPH0810325A (en) | 1994-06-30 | 1994-06-30 | Syringe and container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0810325A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0737484A3 (en) * | 1995-04-12 | 1996-10-30 | Nissho Corporation | Prefilled syringe for injection of two liquids |
JPH10272183A (en) * | 1996-10-28 | 1998-10-13 | Daikyo Seiko:Kk | Syringe with luer lock |
JP2008049082A (en) * | 2006-08-28 | 2008-03-06 | Hisamitsu Pharmaceut Co Inc | Prefilled syringe |
WO2009057572A1 (en) * | 2007-10-30 | 2009-05-07 | Daikyo Seiko, Ltd. | Prefilled nasal drop appliance |
JP2019503815A (en) * | 2016-02-05 | 2019-02-14 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Multi-chamber syringe unit |
-
1994
- 1994-06-30 JP JP6149771A patent/JPH0810325A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0737484A3 (en) * | 1995-04-12 | 1996-10-30 | Nissho Corporation | Prefilled syringe for injection of two liquids |
US5720731A (en) * | 1995-04-12 | 1998-02-24 | Nissho Corporation | Prefilled syringe for injection of two liquids |
JPH10272183A (en) * | 1996-10-28 | 1998-10-13 | Daikyo Seiko:Kk | Syringe with luer lock |
JP2008049082A (en) * | 2006-08-28 | 2008-03-06 | Hisamitsu Pharmaceut Co Inc | Prefilled syringe |
WO2009057572A1 (en) * | 2007-10-30 | 2009-05-07 | Daikyo Seiko, Ltd. | Prefilled nasal drop appliance |
US8276581B2 (en) | 2007-10-30 | 2012-10-02 | Daikyo Seiko, Ltd. | Prefilled type nasal drip appliance |
JP5106542B2 (en) * | 2007-10-30 | 2012-12-26 | 株式会社大協精工 | Prefilled nasal drop device |
JP2019503815A (en) * | 2016-02-05 | 2019-02-14 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Multi-chamber syringe unit |
US11357914B2 (en) | 2016-02-05 | 2022-06-14 | Hoffmann-La Roche Inc. | Multi chamber syringe unit |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0412990Y2 (en) | ||
JP5003155B2 (en) | Prefilled syringe | |
JP3083134B2 (en) | Cannula sealed shield assembly | |
JP4682850B2 (en) | Prefilled syringe | |
US8075547B2 (en) | Autoflush syringe method | |
US7537582B2 (en) | Syringe assembly having disabling mechanism | |
JP2007185319A5 (en) | ||
WO1995017916A1 (en) | Syringe | |
EP1011762A1 (en) | Disposable syringe assembly | |
NZ258210A (en) | Syringe with a plurality of chambers | |
JP2001112867A (en) | Syringe containing drug | |
JPH08280800A (en) | Prefilled syringe for two-liquid injection | |
JPH0527426B2 (en) | ||
BRPI0808477A2 (en) | SYRINGE SET WITH DISABILITY MECHANISM WITH VIOLATION RESISTANCE CHARACTERISTICS | |
JPH0810325A (en) | Syringe and container | |
EP1648541A1 (en) | Syringe assembly having disabling mechanism | |
WO2018173925A1 (en) | Female syringe and syringe kit | |
JPH07246238A (en) | Syringe assembly | |
JP3322450B2 (en) | Infusion container | |
ZA200601413B (en) | Syringe assembly having disabling mechanism | |
JPH09308688A (en) | Syringe with two chambers combined | |
EP0728492B1 (en) | Dual chamber internal by-pass syringe assembly | |
JP4656784B2 (en) | Prefilled syringe | |
JP6975226B2 (en) | Mixing aids and syringe system | |
JPH0810327A (en) | Syringe assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20010821 |